|

Exendin 9-39 Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: no other name for exendin-(9-39)

Pipeline

Early 1: 1Phase 2: 1

Top Sponsors

  • The University of Texas Health Science Center at San Antonio1
  • Mayo Clinic1

Indications

  • Post-bariatric Surgery1
  • PreDiabetes1
  • Weight Loss1
  • Diabetes1

Rochester, Minnesota1 trial

The Role of Islet GLP-1 in the Pathogenesis of Prediabetes

Mayo Clinic in Rochester

Phase 2

San Antonio, Texas1 trial

Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

Texas Diabetes Institute - University Health System

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.